Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating anamorelin hydrochloride for malignancy-associated weight loss and anorexia in adults with advanced non-small cell lung cancer has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Cachexia
• Non-small Cell Lung Cancer

Drugs mentioned

• Anamorelin HCl (anamorelin hydrochloride)

Snippet

Sponsor: Helsinn Healthcare SA | Conditions: Cachexia; Cancer, Non Small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2024-06-26